Unspecified hypogammaglobulinemia
Veno-occlusive disease with immunodeficiency
X-linked lymphoproliferative (XLP) syndromes 1 and 2
Chronic mucocutaneous candidiasis (CMC)
Immunoglobulin product booklet
Use this guide to compare immunoglobulin products approved for use in the U.S.
Sumitomo Pharma
We are united in our mission to advance scientific understanding and deliver meaningful and differentiated therapies that improve the lives of patients in areas of unique and unmet need across multiple therapeutic areas.
Rethymic
Allogeneic processed thymus tissue–agdc.
Approved to treat: Congenital athymia.
Report side effects/adverse reactions at 833-369-9868.

